When we assess these factors alongside standard hormone panels, we gain a more complete picture of whats happening in a womans body
Clinical monitoring of markers such as 8-OHdG or antioxidant enzyme levels does help customize regimens
By bridging the gap between breakthrough pharmacology and everyday lived experience, advanced autoinjector and pen technologies are not merely delivering drugsthey are enabling a sustainable path toward better global health
GLP-1 Story Continues Here are the key figures since Q2 2024: Q2 2024: GLP-1 revenue: $12 million Total revenue: $325 million Share of GLP-1 revenue: 4 % Q3 2024: GLP-1 revenue: $55 million* Total revenue: $441 million Share of GLP-1 revenue: 12 % Q4 2024: GLP-1 revenue: $162 million* Total revenue: $488 million Share of GLP-1 revenue: 33 % Q1 2025: GLP-1 revenue: $ 230 million Total revenue: $596 million Share of GLP-1 revenue: 39 % Q2 2025: GLP-1 revenue: $190 million Total revenue: $545 million Share of GLP-1 revenue: 35 % * Estimate based on the $229M GLP-1 revenue for FY 2024 Revenue Momentum Stalls Amid GLP-1 Reliance Historically Hims has issued conservative guidance and then surpassed the top end of its range
63SommerBG, SutherlandDE, MatasAJ, SimmonsRL, NajarianJS
Mistake 5: incorrect volume measurement Air bubbles in the syringe barrel displace liquid volume
